Lyra Therapeutics

$15.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.49 (-3.17%) As of 5:14 PM UTC today

Why Robinhood?

You can buy or sell LYRA and other stocks, options, and ETFs commission-free!

About LYRA

Lyra Therapeutics, Inc. Common Stock, also called Lyra Therapeutics, is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer and is headquartered in Watertown, MA. The listed name for LYRA is Lyra Therapeutics, Inc. Common Stock.

CEO
Maria Palasis
Employees
—
Headquarters
Watertown, Massachusetts
Founded
2018
Market Cap
188.16M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
272.27K
High Today
$15.67
Low Today
$14.82
Open Price
$15.37
Volume
49.65K
52 Week High
$22.00
52 Week Low
$8.76

LYRA Earnings

-$18.70
-$12.47
-$6.23
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, After Hours

You May Also Like

LMST
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure